Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 avr. 2013 12h00 HE | Source: Calypte Biomedical Corporation

Calypte Biomedical and Maxim Biomedical Announce Joint Distribution of Incidence Testing Assays

PORTLAND, Ore., April 25, 2013 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC) and Maxim Biomedical Inc. today announced a reciprocal distribution agreement under which customers may...
14 oct. 2011 17h27 HE | Source: Calypte Biomedical Corporation

Calypte Biomedical Secures Funding to Conduct Clinical Trials

PORTLAND, Ore., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced that it has entered into...
02 mars 2011 18h57 HE | Source: Calypte Biomedical Corporation

Calypte Biomedical Announces Successful Conclusion of Internal Trials

PORTLAND, Ore., March 2, 2011 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced successful completion of...
08 nov. 2010 14h40 HE | Source: Calypte Biomedical Corporation

Calypte Biomedical Awarded Therapeutic Discovery Project Grant

PORTLAND, Ore., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Calypte Biomedical Corporation (Pink Sheets:CBMC), the developer, manufacturer and marketer of the Aware™ HIV-1/2 OMT (oral fluid) HIV test,...